RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Qing Li to Cell Line, Tumor

This is a "connection" page, showing publications Qing Li has written about Cell Line, Tumor.
Connection Strength

0.811
  1. Liang Z, Zhang B, Xu M, Morisseau C, Hwang SH, Hammock BD, Li QX. 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer's Signaling in Human Nerve Cells. ACS Chem Neurosci. 2019 09 18; 10(9):4018-4030.
    View in: PubMed
    Score: 0.108
  2. Li QQ, Hsu I, Sanford T, Railkar R, Balaji N, Sourbier C, Vocke C, Balaji KC, Agarwal PK. Protein kinase D inhibitor CRT0066101 suppresses bladder cancer growth in vitro and xenografts via blockade of the cell cycle at G2/M. Cell Mol Life Sci. 2018 03; 75(5):939-963.
    View in: PubMed
    Score: 0.095
  3. Li QQ, Hao JJ, Zhang Z, Krane LS, Hammerich KH, Sanford T, Trepel JB, Neckers L, Agarwal PK. Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics. Sci Rep. 2017 03 15; 7(1):201.
    View in: PubMed
    Score: 0.091
  4. Liang Z, Zhang B, Su WW, Williams PG, Li QX. C-Glycosylflavones Alleviate Tau Phosphorylation and Amyloid Neurotoxicity through GSK3? Inhibition. ACS Chem Neurosci. 2016 07 20; 7(7):912-23.
    View in: PubMed
    Score: 0.086
  5. Li QQ, Hao JJ, Zhang Z, Hsu I, Liu Y, Tao Z, Lewi K, Metwalli AR, Agarwal PK. Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach. Int J Oncol. 2016 Jun; 48(6):2591-607.
    View in: PubMed
    Score: 0.085
  6. Li QQ, Lee RX, Liang H, Zhong Y. Anticancer activity of ?-Elemene and its synthetic analogs in human malignant brain tumor cells. Anticancer Res. 2013 Jan; 33(1):65-76.
    View in: PubMed
    Score: 0.068
  7. Li QQ, Lee RX, Liang H, Zhong Y, Reed E. Enhancement of cisplatin-induced apoptosis by ?-elemene in resistant human ovarian cancer cells. Med Oncol. 2013 Mar; 30(1):424.
    View in: PubMed
    Score: 0.068
  8. Liang H, Zhong Y, Zhou S, Li QQ. Palmitic acid-induced apoptosis in pancreatic ?-cells is increased by liver X receptor agonist and attenuated by eicosapentaenoate. In Vivo. 2011 Sep-Oct; 25(5):711-8.
    View in: PubMed
    Score: 0.062
  9. Li QQ, Wang G, Reed E, Huang L, Cuff CF. Evaluation of cisplatin in combination with ?-elemene as a regimen for prostate cancer chemotherapy. Basic Clin Pharmacol Toxicol. 2010 Nov; 107(5):868-76.
    View in: PubMed
    Score: 0.058
  10. Li QQ, Wang G, Huang F, Banda M, Reed E. Antineoplastic effect of beta-elemene on prostate cancer cells and other types of solid tumour cells. J Pharm Pharmacol. 2010 Aug; 62(8):1018-27.
    View in: PubMed
    Score: 0.057
  11. Wu J, Li QQ, Zhou H, Lu Y, Li JM, Ma Y, Wang L, Fu T, Gong X, Weintraub M, Wu S, Ding H. Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas. Med Oncol. 2014 Jul; 31(7):14.
    View in: PubMed
    Score: 0.019
  12. Mo L, Zhang J, Shi J, Xuan Q, Yang X, Qin M, Lee C, Klocker H, Li QQ, Mo Z. Human kallikrein 7 induces epithelial-mesenchymal transition-like changes in prostate carcinoma cells: a role in prostate cancer invasion and progression. Anticancer Res. 2010 Sep; 30(9):3413-20.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support